Chronic HIV-1 infection induces severe immune alterations, including hyperactivation, exhaustion, and apoptosis. In fact, viral control has been associated with low frequencies of these processes. Here, we evaluated the expression of activation and inhibitory molecules on natural killer (NK) and CD4+ T cells and plasma levels of proinflammatory cytokines in individuals exhibiting viral control: a cohort of HIV-1-exposed-seronegative individuals (HESN) and a cohort of HIV controllers. There was lower expression of CD69, LAG-3, PD-1, and TIM-3 in both cohorts when compared to a low-risk population or HIV progressors. In addition, HIV controllers exhibited lower plasma levels of proinflamatory molecules TNF-α and IP-10. These findings suggest that individuals exhibiting viral control have lower basal expression of markers associated with cellular activation and particularly immune exhaustion.
Get full access to this article
View all access options for this article.
References
1.
PiacentiniL, FeniziaC, NaddeoV, et al.: Not just sheer luck! Immune correlates of protection against HIV-1 infection. Vaccine, 2008; 26(24):3002–3007.
2.
BakerBM, BlockBL, RothchildAC, et al.: Elite control of HIV infection: Implications for vaccine design. Expert Opin Biol Ther, 2009; 9(1):55–69.
3.
KoningF, OttoS, HazenbergMD, et al.: Low-level CD4+T cell activation is associated with low susceptibility to HIV-1 infection. J Immunol, 2005; 175(9):6117–6122.
4.
CardCM, RutherfordWJ, RamdahinS, et al.: Reduced cellular susceptibility to in vitro HIV infection is associated with CD4+T cell quiescence. PloS One, 2012; 7(9):e45911.
5.
CardCM, BallTB, and FowkeKR: Immune quiescence: A model of protection against HIV infection. Retrovirology, 2013; 10(1):141.
6.
AlimontiJB, KoestersS, KimaniJ, et al.: CD4+T cell responses in HIV-exposed seronegative women are qualitatively distinct from those in HIV-infected women. J Infect Dis, 2005; 191(1):20–24.
7.
ChenH, LiC, HuangJ, et al.: CD4+T cells from elite controllers resist HIV-1 infection by selective upregulation of p21. J Clin Invest, 2011; 121(4):1549–1560.
8.
SinglaA: Increased activity of NK cells and plasmacytoid dendritic cells in HIV-exposed seronegative (ESN) individuals. World J AIDS, 2012; 02(01):6–16.
9.
MarrasF, NiccoE, BozzanoF, et al.: Natural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulation. Proc Natl Acad Sci USA, 2013; 110:11970–11975.
10.
BrenchleyJM, PriceD, SchackerTW, et al.: Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nature Med, 2006; 12(12):1365–1371.
11.
NoelN, BoufassaF, LécurouxC, et al.: Elevated IP10 levels are associated with immune activation and low CD4+ T-cell counts in HIV controller patients. AIDS, 2014; 28(4):467–476.
12.
NorrisPJ, PappalardoBL, CusterB, et al.: Elevations in IL-10, TNF-alpha, and IFN-gamma from the earliest point of HIV type 1 infection. AIDS Res Hum Retroviruses, 2006; 22(8):757–762.
13.
AsquithB, EdwardsCTT, LipsitchM, et al.: Inefficient cytotoxic T lymphocyte-mediated killing of HIV-1-infected cells in vivo. PLoS Biol, 2006; 4(4):e90.
14.
ParsonsMS, WrenL, IsitmanG, et al.: HIV infection abrogates the functional advantage of natural killer cells educated through KIR3DL1/HLA-Bw4 interactions to mediate anti-HIV antibody-dependent cellular cytotoxicity. J Virol, 2012; 86(8):4488–4495.
15.
KhaitanA and UnutmazD: Revisiting immune exhaustion during HIV infection. Curr HIV/AIDS Rep, 2011; 8(1):4–11.
16.
WongAHW, WilliamsK, ReddyS, et al.: Alterations in natural killer cell receptor profiles during HIV type 1 disease progression among chronically infected South African adults. AIDS Res Hum Retroviruses, 2010; 26(4):459–469.
17.
LajoieJ, KimaniM, PlummerF, et al.: Association of sex work with reduced activation of the mucosal immune system. J Infect Dis, 2014; 210(2):319–329.
18.
ZapataW, Aguilar-JiménezW, Pineda-TrujilloN, et al.: Influence of CCR5 and CCR2 genetic variants in the resistance/susceptibility to HIV in serodiscordant couples from Colombia. AIDS Res Hum Retroviruses, 2013; 29(12):1594–1603.
19.
VelillaPA, HoyosA, RojasM, et al.: Apoptosis as a mechanism of natural resistance to HIV-1 infection in an exposed but uninfected population. J Clin Virol, 2005; 32(4):329–335.
20.
ZapataW, RodriguezB, WeberJ, et al.: Increased levels of human beta-defensins mRNA in sexually HIV-1 exposed but uninfected individuals. Curr HIV Res, 2008; 6(6):531–538.
21.
ClericiM, BarassiC, DevitoC, et al.: Serum IgA of HIV-exposed uninfected individuals inhibit HIV through recognition of a region within the alpha-helix of gp41. AIDS, 2002; 16(13):1731–1741.
22.
HladikF, LiuH, SpeelmonE, et al.: Combined effect of CCR5-delta32 heterozygosity and the CCR5 promoter polymorphism -2459 A/G on CCR5 expression and resistance to human immunodeficiency virus type 1 transmission. J Virol, 2005; 79(18):11677–11684.
23.
MontoyaCJ, VelillaPA, ChougnetC, et al.: Increased IFN-gamma production by NK and CD3+/CD56+cells in sexually HIV-1-exposed but uninfected individuals. Clin Immunol, 2006; 120(2):138–146.
24.
LajoieJ, JunoJ, BurgenerA, et al.: A distinct cytokine and chemokine profile at the genital mucosa is associated with HIV-1 protection among HIV-exposed seronegative commercial sex workers. Mucosal Immunol, 2012; 5(3):277–287.
25.
KoningFA, OttoSA, HazenbergMD, et al.: Low-level CD4+T cell activation is associated with low susceptibility to HIV-1 infection. J Immunol, 2005; 175(9):6117–6122.
26.
BégaudE, ChartierL, MarechalV, et al.: Reduced CD4 T cell activation and in vitro susceptibility to HIV-1 infection in exposed uninfected Central Africans. Retrovirology, 2006; 3:35.
27.
McLarenPJ, BallTB, WachihiC, et al.: HIV‐exposed seronegative commercial sex workers show a quiescent phenotype in the CD4+T cell compartment and reduced expression of HIV‐dependent host factors. J Infect Dis, 2010; 202(Suppl):S339–344.
28.
SongokEM, LuoM, LiangB, et al.: Microarray analysis of HIV resistant female sex workers reveal a gene expression signature pattern reminiscent of a lowered immune activation state. PloS One, 2012; 7(1):e30048.
29.
MeierA, BagchiA, SidhuHK, et al.: Upregulation of PD-L1 on monocytes and dendritic cells by HIV-1 derived TLR ligands. AIDS, 2008; 22(5):655–658.
30.
CheKF, SabadoRL, ShankarEM, et al.: HIV-1 impairs in vitro priming of naïve T cells and gives rise to contact-dependent suppressor T cells. Eur J Immunol, 2010; 40(8):2248–2258.
31.
ZhangG, LiuZ, DuanS, et al.: Association of polymorphisms of programmed cell death-1 gene with chronic hepatitis B virus infection. Hum Immunol, 2010; 71(12):1209–1213.
32.
LiZ, LiN, ZhuQ, et al.: Genetic variations of PD1 and TIM3 are differentially and interactively associated with the development of cirrhosis and HCC in patients with chronic HBV infection. Infect Genet Evol, 2013; 14:240–246.
33.
DuanS, ZhangG, HanQ, et al.: CTLA-4 exon 1+49 polymorphism alone and in a haplotype with -318 promoter polymorphism may confer susceptibility to chronic HBV infection in Chinese Han patients. Mol Biol Rep, 2011; 38(8):5125–5132.
34.
SironiM, BiasinM, GnudiF, et al.: A regulatory polymorphism in HAVCR2 modulates susceptibility to HIV-1 infection. PloS One, 2014; 9(9):e106442.
35.
NdhlovuLC, Lopez-vergeS, BarbourJD, et al.: Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity. Blood, 2012; 119(16):3734–3743.
36.
HazenbergMD, OttoS, van BenthemBHB, et al.: Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS, 2003; 17(13):1881–1888.
37.
ZhangJ-Y, ZhangZ, WangX, et al.: PD-1 up-regulation is correlated with HIV-specific memory CD8+T-cell exhaustion in typical progressors but not in long-term nonprogressors. Blood, 2007; 109(11):4671–4678.
38.
LengQ, BentwichZ, MagenE, et al.: CTLA-4 upregulation during HIV infection: Association with anergy and possible target for therapeutic intervention. AIDS, 2002; 16(4):519–529.
39.
DayCL, KaufmannDE, KiepielaP, et al.: PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature, 2006; 443(7109):350–354.
40.
JonesRB, NdhlovuLC, BarbourJD, et al.: Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. J Exp Med, 2008; 205(12):2763–2779.
41.
PriceP, KeaneN, GrayL, et al.: CXCR4 or CCR5 tropism of human immunodeficiency virus type 1 isolates does not determine the immunological milieu in patients responding to antiretroviral therapy. Viral Immunol, 2006; 19(4):734–740.
42.
WilliamsLD, BansalA, SabbajS, et al.: Interleukin-21-producing HIV-1-specific CD8 T cells are preferentially seen in elite controllers. J Virol, 2011; 85(5):2316–2324.
43.
HerspergerAR, PereyraF, NasonM, et al.: Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control. PLoS Pathog, 2010; 6(5):e1000917.
44.
TiemessenCT, ShalekoffS, Meddows-TaylorS, et al.: Natural killer cells that respond to human immunodeficiency virus type 1 (HIV-1) peptides are associated with control of HIV-1 infection. J Infect Dis, 2010; 202(9):1444–1453.
45.
PereyraF, PalmerS, MiuraT, et al.: Persistent low-level viremia in HIV-1 elite controllers and relationship to immunologic parameters. J Infect Dis, 2009; 200(6):984–990.
46.
TabordaNA, CatañoJC, DelgadoJC, et al.: Higher SLPI expression, lower immune activation, and increased frequency of immune cells in a cohort of Colombian HIV-1 controllers. J Acquir Immune Defic Syndr, 2012; 60(1):12–19.
